Lexeo Therapeutics News

Lexeo Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 11 04:44

Lexeo Therapeutics | 424B3: Prospectus

Aug 12 19:15

Lexeo Therapeutics | 424B3: Prospectus

Jul 15 20:04

Lexeo Therapeutics | 424B3: Prospectus

Jul 8 19:07

Lexeo Therapeutics | 424B3: Prospectus

Jun 28 19:37

Lexeo Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 14 05:19

Lexeo Therapeutics | 424B3: Prospectus

May 9 19:12

Lexeo Therapeutics | 424B3: Prospectus

Apr 22 20:30

Lexeo Therapeutics | 424B3: Prospectus

Apr 22 20:25

Lexeo Therapeutics | 424B3: Prospectus

Apr 16 19:39

Lexeo Therapeutics | EFFECT: Others

Apr 15 18:19

Lexeo Therapeutics | 424B3: Prospectus

Apr 13 05:08

Lexeo Therapeutics | 424B4: Prospectus

Nov 7, 2023 05:54

Lexeo Therapeutics | EFFECT: Others

Nov 3, 2023 12:16

Lexeo Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 3, 2023 09:01

Lexeo Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Nov 2, 2023 04:01